The Top News from the pharmaceutical sector this week reflects a rapidly evolving landscape driven by innovation, regulation, and global health priorities
The pharmaceutical industry continues to evolve, driven by regulatory shifts, legal battles, clinical trial outcomes, strategic partnerships, and strong commercial performance
India’s rapid healthcare expansion highlights the urgent need to ensure that growth translates into making healthcare affordable for a larger population
India is strengthening its healthcare ecosystem through new institutional collaborations to accelerate Medical Research in India, with a clear focus on improving patient-centric outcomes through data-backed and evidence-based practices
The latest BRICS Health Ministers’ meeting signals a notable shift in that direction, also mental health is increasingly gaining recognition as a critical component of global healthcare
Cipla has reported its highest-ever quarterly sales record in India, marking a strong start to Q1 FY27. The company's domestic business grew 12 percent year-on-year and became the biggest growth driver. Cipla also delivered steady gains across globa
Roche has reaffirmed its full-year guidance, keeping Roche's Growth Story alive despite Vabysmo slowdown sales and ongoing currency headwinds.
The pharmaceutical and healthcare industry continues to evolve rapidly, driven by policy changes, strategic investments, scientific breakthroughs, and regulatory developments.
Patients using GLP-1 drugs for obesity and type 2 diabetes may have a slightly higher chance of developing hair loss, according to three new studies.
GSK has received Early FDA Approval for its new lung cancer drug, Jideytro. The decision marks a major milestone for the company as it enters the competitive market for targeted lung cancer therapies.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")